Journal of Hepatology
Volume 52, Issue 5 , Pages 644-651 , May 2010

The scavenger receptors SRA-1 and SREC-I cooperate with TLR2 in the recognition of the hepatitis C virus non-structural protein 3 by dendritic cells

  • Céline Beauvillain

      Affiliations

    • Institut National de la Santé et de la Recherche Médicale – Inserm, Unité 892, Centre de Recherche en Cancérologie Nantes-Angers, Bâtiment Montéclair, 4 rue Larrey, Angers 49933, France
    • Université d’Angers, UMR_S 892, Angers, France
    • CHU d’Angers, Laboratoire d’Immunologie et d’Allergologie, Angers, France
    • ,
  • Francesca Meloni

      Affiliations

    • Istituto Pasteur-Cenci Bolognetti, Università degli Studi di Roma “La Sapienza”, Roma, Italy
    • ,
  • Jean-Claude Sirard

      Affiliations

    • Institut Pasteur de Lille, Inserm, Unité 801, Lille, France
    • ,
  • Simon Blanchard

      Affiliations

    • Institut National de la Santé et de la Recherche Médicale – Inserm, Unité 892, Centre de Recherche en Cancérologie Nantes-Angers, Bâtiment Montéclair, 4 rue Larrey, Angers 49933, France
    • Université d’Angers, UMR_S 892, Angers, France
    • CHU d’Angers, Laboratoire d’Immunologie et d’Allergologie, Angers, France
    • ,
  • Ulrich Jarry

      Affiliations

    • Institut National de la Santé et de la Recherche Médicale – Inserm, Unité 892, Centre de Recherche en Cancérologie Nantes-Angers, Bâtiment Montéclair, 4 rue Larrey, Angers 49933, France
    • Université d’Angers, UMR_S 892, Angers, France
    • ,
  • Mari Scotet

      Affiliations

    • Institut National de la Santé et de la Recherche Médicale – Inserm, Unité 892, Centre de Recherche en Cancérologie Nantes-Angers, Bâtiment Montéclair, 4 rue Larrey, Angers 49933, France
    • Université d’Angers, UMR_S 892, Angers, France
    • ,
  • Giovanni Magistrelli

      Affiliations

    • NovImmune SA, Plan-les-Ouates, Geneva, Switzerland
    • ,
  • Yves Delneste

      Affiliations

    • Institut National de la Santé et de la Recherche Médicale – Inserm, Unité 892, Centre de Recherche en Cancérologie Nantes-Angers, Bâtiment Montéclair, 4 rue Larrey, Angers 49933, France
    • Université d’Angers, UMR_S 892, Angers, France
    • CHU d’Angers, Laboratoire d’Immunologie et d’Allergologie, Angers, France
    • ,
  • Vincenzo Barnaba

      Affiliations

    • Istituto Pasteur-Cenci Bolognetti, Università degli Studi di Roma “La Sapienza”, Roma, Italy
    • ,
  • Pascale Jeannin

      Affiliations

    • Institut National de la Santé et de la Recherche Médicale – Inserm, Unité 892, Centre de Recherche en Cancérologie Nantes-Angers, Bâtiment Montéclair, 4 rue Larrey, Angers 49933, France
    • Université d’Angers, UMR_S 892, Angers, France
    • CHU d’Angers, Laboratoire d’Immunologie et d’Allergologie, Angers, France
    • Corresponding Author InformationCorresponding author. Tel.: +33 (0) 241 735952; fax: +33 (0) 241 354 121.

Received 10 September 2009 ,Revised 24 November 2009 ,Accepted 25 November 2009.

References 

  1. Palm NW, Medzhitov R. Pattern recognition receptors and control of adaptive immunity. Immunol Rev. 2009;227:221–233
  2. Takamizawa A, Mori C, Fuke I, Manabe S, Murakami S, Fujita J, et al. Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol. 1991;65:1105–1113
  3. Hoofnagle JH. Course and outcome of hepatitis C. Hepatology. 2002;36:S21–S29
  4. Manns MP, Wedemeyer H, Cornberg M. Treating viral hepatitis C: efficacy, side effects, and complications. Gut. 2006;55:1350–1359
  5. Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, et al. Binding of hepatitis C virus to CD81. Science. 1998;282:938–941
  6. Meertens L, Bertaux C, Cukierman L, Cormier E, Lavillette D, Cosset FL, et al. The tight junction proteins claudin-1, -6, and -9 are entry cofactors for hepatitis C virus. J Virol. 2008;82:3555–3560
  7. Germi R, Crance JM, Garin D, Guimet J, Lortat-Jacob H, Ruigrok RW, et al. Cellular glycosaminoglycans and low density lipoprotein receptor are involved in hepatitis C virus adsorption. J Med Virol. 2002;68:206–215
  8. Saito T, Gale M. Regulation of innate immunity against hepatitis C virus infection. Hepatol Res. 2008;38:115–122
  9. Scarselli E, Ansuini H, Cerino R, Roccasecca RM, Acali S, Filocamo G, et al. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J. 2002;21:5017–5025
  10. Bartosch B, Vitelli A, Granier C, Goujon C, Dubuisson J, Pascale S, et al. Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor. J Biol Chem. 2003;278:41624–41630
  11. Saito T, Owen DM, Jiang F, Marcotrigiano J, Gale M. Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature. 2008;454:523–527
  12. Foy E, Li K, Sumpter R, Loo YM, Johnson CL, Wang C, et al. Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. Proc Natl Acad Sci USA. 2005;102:2986–2991
  13. Li K, Foy E, Ferreon JC, Nakamura M, Ferreon AC, Ikeda M, et al. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci USA. 2005;102:2992–2997
  14. Lamonaca V, Missale G, Urbani S, Pilli M, Boni C, Mori C, et al. Conserved hepatitis C virus sequences are highly immunogenic for CD4(+) T cells: implications for vaccine development. Hepatology. 1999;30:1088–1098
  15. Fytili P, Dalekos GN, Schlaphoff V, Suneetha PV, Sarrazin C, Zauner W, et al. Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3–1073. Vaccine. 2008;26:3818–3826
  16. Dolganiuc A, Oak S, Kodys K, Golenbock DT, Finberg RW, Kurt-Jones E, et al. Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation. Gastroenterology. 2004;127:1513–1524
  17. Chang S, Dolganiuc A, Szabo G. Toll-like receptors 1 and 6 are involved in TLR2-mediated macrophage activation by hepatitis C virus core and NS3 proteins. J Leukoc Biol. 2007;82:479–487
  18. Accapezzato D, Visco V, Francavilla V, Molette C, Donato T, Paroli M, et al. Chloroquine enhances human CD8+ T cell responses against soluble antigens in vivo. J Exp Med. 2005;202:817–828
  19. Jin B, Wang RY, Qiu Q, Sugauchi F, Grandinetti T, Alter HJ, et al. Induction of potent cellular immune response in mice by hepatitis C virus NS3 protein with double-stranded RNA. Immunology. 2007;122:15–27
  20. Castellino F, Boucher PE, Eichelberg K, Mayhew M, Rothman JE, Houghton AN, et al. Receptor-mediated uptake of antigen/heat shock protein complexes results in major histocompatibility complex class I antigen presentation via two distinct processing pathways. J Exp Med. 2000;191:1957–1964
  21. Steiner TS, Nataro JP, Poteet-Smith CE, Smith JA, Guerrant RL. Enteroaggregative Escherichia coli expresses a novel flagellin that causes IL-8 release from intestinal epithelial cells. J Clin Invest. 2000;105:1769–1777
  22. Abraham R, Singh N, Mukhopadhyay A, Basu SK, Bal V, Rath S. Modulation of immunogenicity and antigenicity of proteins by maleylation to target scavenger receptors on macrophages. J Immunol. 1995;154:1–8
  23. Jeannin P, Magistrelli G, Herbault N, Goetsch L, Godefroy S, Charbonnier P, et al. Outer membrane protein A renders dendritic cells and macrophages responsive to CCL21 and triggers dendritic cell migration to secondary lymphoid organs. Eur J Immunol. 2003;33:326–333
  24. Jeannin P, Renno T, Goetsch L, Miconnet I, Aubry JP, Delneste Y, et al. OmpA targets dendritic cells, induces their maturation and delivers antigen into the MHC class I presentation pathway. Nat Immunol. 2000;1:502–509
  25. Delneste Y, Magistrelli G, Gauchat J, Haeuw J, Aubry J, Nakamura K, et al. Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation. Immunity. 2002;17:353–362
  26. Areschoug T, Gordon S. Scavenger receptors: role in innate immunity and microbial pathogenesis. Cell Microbiol. 2009;11:1160–1169
  27. Cambi A, Figdor CG. Levels of complexity in pathogen recognition by C-type lectins. Curr Opin Immunol. 2005;17:345–351
  28. Guermonprez P, Khelef N, Blouin E, Rieu P, Ricciardi-Castagnoli P, Guiso N, et al. The adenylate cyclase toxin of Bordetella pertussis binds to target cells via the alpha(M)beta(2) integrin (CD11b/CD18). J Exp Med. 2001;193:1035–1044
  29. Jeannin P, Jaillon S, Delneste Y. Pattern recognition receptors in the immune response against dying cells. Curr Opin Immunol. 2008;20:530–537
  30. Berwin B, Delneste Y, Lovingood RV, Post SR, Pizzo SV. SREC-I, a type F scavenger receptor, is an endocytic receptor for calreticulin. J Biol Chem. 2004;279:51250–51257
  31. Berwin B, Hart JP, Rice S, Gass C, Pizzo SV, Post SR, et al. Scavenger receptor-A mediates gp96/GRP94 and calreticulin internalization by antigen-presenting cells. EMBO J. 2003;22:6127–6136
  32. Jeannin P, Bottazzi B, Sironi M, Doni A, Rusnati M, Presta M, et al. Complexity and complementarity of outer membrane protein A recognition by cellular and humoral innate immunity receptors. Immunity. 2005;22:551–560
  33. Rock KL. Exiting the outside world for cross-presentation. Immunity. 2006;25:523–525
  34. Green DR, Ferguson T, Zitvogel L, Kroemer G. Immunogenic and tolerogenic cell death. Nat Rev. 2009;9:353–363
  35. Yamasaki Y, Ikenaga T, Otsuki T, Nishikawa M, Takakura Y. Induction of antigen-specific cytotoxic T lymphocytes by immunization with negatively charged soluble antigen through scavenger receptor-mediated delivery. Vaccine. 2007;25:85–91
  36. Theriault JR, Adachi H, Calderwood SK. Role of scavenger receptors in the binding and internalization of heat shock protein 70. J Immunol. 2006;177:8604–8611
  37. Barth H, Schnober EK, Neumann-Haefelin C, Thumann C, Zeisel MB, Diepolder HM, et al. Scavenger receptor class B is required for hepatitis C virus uptake and cross-presentation by human dendritic cells. J Virol. 2008;82:3466–3479
  38. Xie L, Wu XD, Huang DZ, Chen HL, He LX, Wang J, et al. Clinical application and analysis of hepatitis C virus NS3 antigen detection by ELISA in human serum. Chin Med J (Engl). 2007;120:294–299

☆ The authors who have taken part in this study do not have anything to declare regarding funding from industry or conflicts of interest with respect to this manuscript.

PII: S0168-8278(10)00093-0

doi: 10.1016/j.jhep.2009.11.031

Journal of Hepatology
Volume 52, Issue 5 , Pages 644-651 , May 2010

Article Tools

* Image Usage & Resolution